Drug Shortage Report for ACH-TADALAFIL
| Report ID | 195319 |
| Drug Identification Number | 02516004 |
| Brand name | ACH-TADALAFIL |
| Common or Proper name | Tadalafil |
| Company Name | ACCORD HEALTHCARE INC |
| Market Status | MARKETED |
| Active Ingredient(s) | TADALAFIL |
| Strength(s) | 20MG |
| Dosage form(s) | TABLET |
| Route of administration | ORAL |
| Packaging size | 4 |
| ATC code | G04BE |
| ATC description | OTHER UROLOGICALS, INCL ANTISPASMODICS |
| Reason for shortage | Requirements related to complying with good manufacturing practices. |
| Anticipated start date | |
| Actual start date | 2023-06-16 |
| Estimated end date | |
| Actual end date | 2023-09-15 |
| Shortage status | Resolved |
| Updated date | 2023-09-16 |
| Company comments | |
| Health Canada comments | |
| Tier 3 Status | No |
| Company contact information | Customer Service at (514) 505-4159 ext. 203 | Service à la clientèle à (514) 505-4159 poste 203 |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
| Version Number | Date Updated | Language | |
|---|---|---|---|
| v5 | 2023-09-16 | English | Compare |
| v4 | 2023-09-15 | French | Compare |
| v3 | 2023-09-15 | English | Compare |
| v2 | 2023-06-16 | French | Compare |
| v1 | 2023-06-16 | English | Compare |
Showing 1 to 5 of 5